End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 CNY | +4.91% | +2.62% | -17.25% |
04-15 | Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | Biocause Pharma’s Insurance Unit Posts Steady Annual Premium in 2023 | MT |
Chart calendar Hubei Biocause Pharmaceutical Co., Ltd.
Upcoming events on Hubei Biocause Pharmaceutical Co., Ltd.
Past events on Hubei Biocause Pharmaceutical Co., Ltd.
29/01/2024 06:00 | Extraordinary Shareholders Meeting |
30/10/2023 | Q3 2023 Earnings Release |
30/08/2023 | Q2 2023 Earnings Release |
19/05/2023 07:00 | Annual General Meeting |
27/04/2023 | Q1 2023 Earnings Release |
23/12/2022 06:00 | Extraordinary Shareholders Meeting |
28/10/2022 | Q3 2022 Earnings Release |
29/08/2022 | Interim 2022 Earnings Release |
23/05/2022 07:00 | Annual General Meeting |
29/04/2022 | Q1 2022 Earnings Release |
29/04/2022 | FY 2021 Earnings Release |
29/10/2021 | Q3 2021 Earnings Release |
30/08/2021 | Interim 2021 Earnings Release |
20/08/2021 07:00 | Extraordinary Shareholders Meeting |
21/05/2021 07:00 | Annual General Meeting |
29/04/2021 | Q1 2021 Earnings Release |
29/04/2021 | FY 2020 Earnings Release |
25/01/2021 06:00 | Extraordinary Shareholders Meeting |
30/10/2020 | Q3 2020 Earnings Release |
24/09/2020 | Extraordinary Shareholders Meeting |
Past dividends on Hubei Biocause Pharmaceutical Co., Ltd.
29/05/2023 | Annual 0.11 CNY |
01/06/2022 | Annual 0.005 CNY |
03/06/2021 | Annual 0.01 CNY |
19/05/2020 | Final Payment 0.1 CNY |
25/09/2019 | Interim Payment 0.03 CNY |
11/10/2018 | Interim Payment 0.03 CNY |
07/06/2018 | Annual 0.01 CNY |
20/06/2017 | Annual 0.025 CNY |
13/04/2016 | Annual 0.009534 CNY |
Annual results
Fiscal Period | December | 2019 | 2022 |
---|---|---|---|
Net sales | Released Forecast Spread | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
EBIT | Released Forecast Spread | 0,00 | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 |
Net income Million CNY | Released Forecast Spread | 1 776 | 274 |
EPS CNY | Released Forecast Spread | 0,36 | 0,06 |
Announcement Date | 14/04/20 | 14/04/23 |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
29/04/2024 | STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED: Q4 2024 Earnings Release |
30/04/2024 21:15 | UNUM GROUP: Q1 2024 Earnings Release |
30/04/2024 21:15 | PRUDENTIAL FINANCIAL, INC.: Q1 2024 Earnings Release |
30/04/2024 | METLIFE, INC.: Q1 2024 Earnings Release |
30/04/2024 | AFLAC INCORPORATED: Q1 2024 Earnings Release |
30/04/2024 | GREAT-WEST LIFECO INC.: Q1 2024 Earnings Release |
01/05/2024 | HANWHA CORPORATION: Q1 2024 Earnings Release |
02/05/2024 12:00 | LINCOLN NATIONAL CORPORATION: Q1 2024 Earnings Release |
Past sector events for Hubei Biocause Pharmaceutical Co., Ltd.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 000627 Stock
- Calendar Hubei Biocause Pharmaceutical Co., Ltd.